Capsule types driving carbapenem-resistant Klebsiella pneumoniae in Pakistan are largely absent from the phage literature
Phage therapy is increasingly proposed for carbapenem-resistant Klebsiella pneumoniae, but most Klebsiella phages bind a single capsule type, so a phage is useful only where its capsule type circulates. We asked whether published phages cover the capsule types found in Pakistani patients. We typed 254 clinical K. pneumoniae genomes from Pakistan and curated the phage and depolymerase literature…
Klebsiella pneumoniae, a multi-drug resistant bacterium, faces challenges in infection due to nutrient limitations imposed by the host's immune system. This includes iron and zinc deficiencies, which the bacterium must overcome through a process known as nutritional immunity. Siderophores, small molecule molecules that bind iron, are crucial virulence factors in Klebsiella pneumoniae pathogenesis.
The study aimed to understand how multi-drug resistant K. pneumoniae grows in environments limited by zinc. Through unbiased transcriptomics, proteomics, and an arrayed transposon screen, the research found that synthesis and uptake of the siderophore enterobactin are essential for growth in low zinc conditions. Iron-specific chelators did not replicate this growth phenotype, and adding supplemental iron to the growth media could not correct the severe growth defects observed in enterobactin mutant K. pneumoniae experiencing zinc limitation.
The study also revealed that zinc starvation induces enterobactin production independent of the usual zinc uptake regulator (Zur) transcription factor, suggesting an unidentified regulatory mechanism that may help Gram-negative pathogens respond to zinc stress. This research broadens the role of enterobactin beyond iron regulation and identifies a previously unknown connection between iron and zinc homeostasis in Klebsiella pneumoniae.
Written by urgent.news from bioRxiv's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.